Literature DB >> 24375315

Evaluation of urinary HURP mRNA as a marker for detection of bladder cancer: relation to bilharziasis.

Sanaa Eissa1, Marwa Matboli, Amal Mansour, Shimaa Mohamed, Nahla Awad, Youssef M Kotb.   

Abstract

This study was carried out to assess the efficacy of urinary hepatoma up-regulated protein (HURP) RNA in bladder cancer diagnosis and its relation to bilharziasis. Voided urine samples and blood were collected from 344 consecutive participants: 211 patients diagnosed with bladder cancer, 71 patients with benign urological disorders and 62 healthy volunteers. Serologic assessment of schistosomiasis antibody in sera, urine cytology and estimation of HURP RNA by reverse transcription polymerase chain reaction in urothelial cells was carried out in all samples. HURP RNA expression showed a significant difference among the three investigated groups. The best cutoff point for HURP RNA was determined as 0.0132 at 78.67 % sensitivity and 94 % specificity. The sensitivity of urine cytology was improved when combined with HURP RNA in detection of early stage (77.3 %), low grade (85.3 %) and bilharzial bladder cancer (78.1 %). Detection of urinary HURP RNA is a useful non-invasive test for early detection of bladder cancer and bilharzial bladder cancer and it improves sensitivity of urine cytology up to 91 %.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24375315     DOI: 10.1007/s12032-013-0804-4

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  23 in total

1.  Urinary bladder cancer risk factors in Egypt: a multicenter case-control study.

Authors:  Yun-Ling Zheng; Sania Amr; Doa'a A Saleh; Chiranjeev Dash; Sameera Ezzat; Nabiel N Mikhail; Iman Gouda; Iman Loay; Tamer Hifnawy; Mohamed Abdel-Hamid; Hussein Khaled; Beverly Wolpert; Mohamed A Abdel-Aziz; Christopher A Loffredo
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-12-06       Impact factor: 4.254

2.  Aurora A regulates the activity of HURP by controlling the accessibility of its microtubule-binding domain.

Authors:  Jim Wong; Robert Lerrigo; Chang-Young Jang; Guowei Fang
Journal:  Mol Biol Cell       Date:  2008-03-05       Impact factor: 4.138

3.  Diagnostic value of fibronectin and mutant p53 in the urine of patients with bladder cancer: impact on clinicopathological features and disease recurrence.

Authors:  Sanaa Eissa; Samir F Zohny; Abdel-Rahman N Zekri; Tarek Mostafa El-Zayat; Amany M Maher
Journal:  Med Oncol       Date:  2009-12-11       Impact factor: 3.064

Review 4.  Molecular markers in bladder cancer: a critical appraisal.

Authors:  Badrinath R Konety
Journal:  Urol Oncol       Date:  2006 Jul-Aug       Impact factor: 3.498

5.  Aberrant methylation of RARbeta2 and APC genes in voided urine as molecular markers for early detection of bilharzial and nonbilharzial bladder cancer.

Authors:  Sanaa Eissa; Menha Swellam; Inas M El-Khouly; Samar K Kassim; Hanan Shehata; Amal Mansour; Mohamed Esmat; Ahmed Ibrahim Nossier; Mohamed A Hamdy; Nahla M Awad; Omar El-Ahmady
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-06-15       Impact factor: 4.254

6.  Potential molecular marker for detecting transitional cell carcinoma.

Authors:  Allen W Chiu; Yu-Lun Huang; Steven K Huan; Yu-Chun Wang; Jyh-Phen Ju; Mei-Fang Chen; Chen-Kung Chou
Journal:  Urology       Date:  2002-07       Impact factor: 2.649

7.  CpG island methylation in Schistosoma- and non-Schistosoma-associated bladder cancer.

Authors:  Marina I Gutiérrez; Abdul K Siraj; Hussein Khaled; Natalie Koon; Wa'el El-Rifai; Kishor Bhatia
Journal:  Mod Pathol       Date:  2004-10       Impact factor: 7.842

8.  Identification of a novel cell cycle regulated gene, HURP, overexpressed in human hepatocellular carcinoma.

Authors:  Ann-Ping Tsou; Chu-Wen Yang; Chi-Ying F Huang; Ricky Chang-Tze Yu; Yuan-Chii G Lee; Cha-Wei Chang; Bo-Rue Chen; Yu-Fang Chung; Ming-Ji Fann; Chin-Wen Chi; Jen-Hwey Chiu; Chen-Kung Chou
Journal:  Oncogene       Date:  2003-01-16       Impact factor: 9.867

9.  Reactivity of Schistosoma japonicum and S. mansoni antigen preparations in indirect haemagglutination (IHA) with sera of patients with homologous and heterologous schistosomiasis.

Authors:  M Gui; M A Idris; Y E Shi; A Mühling; A Ruppel
Journal:  Ann Trop Med Parasitol       Date:  1991-12

10.  A semi-quantitative RT-PCR method to measure the in vivo effect of dietary conjugated linoleic acid on porcine muscle PPAR gene expression.

Authors:  W J Meadus
Journal:  Biol Proced Online       Date:  2003-02-17       Impact factor: 3.244

View more
  4 in total

1.  Evaluation and screening of mRNA S100A genes as serological biomarkers in different stages of bladder cancer in Egypt.

Authors:  Manal F Ismail; Noha A El Boghdady; Marwa I Shabayek; Heba A Awida; Hamdy Abozeed
Journal:  Tumour Biol       Date:  2015-10-27

2.  NQO1 is Required for β-Lapachone-Mediated Downregulation of Breast-Cancer Stem-Cell Activity.

Authors:  Dong Wook Kim; Je-Yoel Cho
Journal:  Int J Mol Sci       Date:  2018-11-30       Impact factor: 6.208

3.  Transcriptome analysis identifies putative multi-gene signature distinguishing benign and malignant pancreatic head mass.

Authors:  Bishnupriya Chhatriya; Moumita Mukherjee; Sukanta Ray; Barsha Saha; Somdatta Lahiri; Sandip Halder; Indranil Ghosh; Sujan Khamrui; Kshaunish Das; Samsiddhi Bhattacharjee; Saroj Kant Mohapatra; Srikanta Goswami
Journal:  J Transl Med       Date:  2020-11-07       Impact factor: 5.531

4.  NEAT1/MALAT1/XIST/PKD--Hsa-Mir-101-3p--DLGAP5 Axis as a Novel Diagnostic and Prognostic Biomarker Associated With Immune Cell Infiltration in Bladder Cancer.

Authors:  Xiaosheng Rao; Haiyan Cao; Qingfeng Yu; Xiuyu Ou; Ruiqi Deng; Jinkun Huang
Journal:  Front Genet       Date:  2022-07-08       Impact factor: 4.772

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.